Study: Effects of two dosing regimens of Netarsudil in patients with Fuchs corneal dystrophy

Richard L. Lindstrom, MD, of Minnesota Eye Consultants, discusses his ASCRS presentation, "Randomized, Open-Label, Parallel-Group Study of Two Dosing Regimens of Netarsudil in Patients with Fuchs Corneal Dystrophy," with Ophthalmology Times' Sheryl Stevenson.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.